Hanchorbio Inc (7827)

Currency in TWD
156.50
0.00(0.00%)
Closed·
7827 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
152.00157.50
52 wk Range
63.70187.00
Key Statistics
Bid/Ask
154.00 / 156.50
Prev. Close
156.5
Open
155
Day's Range
152-157.5
52 wk Range
63.7-187
Volume
372.2K
Average Volume (3m)
263.54K
1-Year Change
102.7202%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
7827 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
High return over the last year

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Earnings

Latest Release
Aug 28, 2026
EPS / Forecast
-1,88 / --
Revenue / Forecast
9,54M / --
EPS Revisions
Last 90 days

7827 Income Statement

Compare 7827 to Peers and Sector

Metrics to compare
7827
Peers
Sector
Relationship
P/E Ratio
−38.3x−2.4x−0.3x
PEG Ratio
−0.64−0.030.00
Price/Book
16.5x3.4x2.6x
Price / LTM Sales
68.1x16.5x2.9x
Upside (Analyst Target)
-286.6%62.0%
Fair Value Upside
Unlock−4.6%9.5%Unlock

HanchorBio Inc. engages in the research and development of new anti-cancer drugs in Hong Kong and Mainland China. The companys product pipeline consists of HCB101, which is in phase II clinical trial to treat head and neck cancer, triple-negative breast cancer, gastric cancer, colorectal cancer, and small cell lung cancer; HCB301, which is in phase I clinical trial for the treatment of hematologic malignancies, head and neck cancer, and solid tumors; and HCB303, which is in preclinical trial to treat hematologic malignancies, head and neck cancer, and solid tumors. Its technology is the Fc-Based Designer Biologics platform, which focuses on the development of next-generation immuno-oncology fusion protein therapeutic. HanchorBio Inc. was founded in 2008 and is based in Taipei, Taiwan.

Employees
125
Market
Taiwan

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
41,00K0,03%6,42M
Other Institutional Investors
29,75M21,25%4,66B
Public Companies & Retail Investors
110,19M78,72%17,24B
Total
139,97M100,00%21,91B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Affinity Capital4,12%5 762 223901 788
Anfu Great Health No. 24,12%5 762 223901 788

FAQ

What Is the Hanchorbio (7827) Stock Price Today?

The Hanchorbio stock price today is 156,50 TWD.

What Stock Exchange Does Hanchorbio Trade On?

Hanchorbio is listed and trades on the Taiwan Stock Exchange.

What Is the Stock Symbol for Hanchorbio?

The stock symbol for Hanchorbio is "7827."

What Is the Hanchorbio Market Cap?

As of today, Hanchorbio market cap is 21,91B TWD.

What Is Hanchorbio's Earnings Per Share (TTM)?

The Hanchorbio EPS (TTM) is -4,45.

From a Technical Analysis Perspective, Is 7827 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Hanchorbio Stock Split?

Hanchorbio has split 0 times.

How Many Employees Does Hanchorbio Have?

Hanchorbio has 125 employees.

What is the current trading status of Hanchorbio (7827)?

As of Oct 20, 2026, Hanchorbio (7827) is trading at a price of 156,50 TWD, with a previous close of 156,50 TWD. The stock has fluctuated within a day range of 152,00 TWD to 157,50 TWD, while its 52-week range spans from 63,70 TWD to 187,00 TWD.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.